The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients

M. Tampellini, A. Saini, I. Alabiso, R. Bitossi, M. P. Brizzi, C. M. Sculli, A. Berruti, G. Gorzegno, A. Magnino, E. Sperti, S. Miraglia, L. Forti, O. Alabiso, M. Aglietta, A. Harris, L. Dogliotti

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The purpose of the study was to evaluate the influence of baseline haemoglobin level in predicting response to 5-fluorouracil (5FU)-based first-line chemotherapy in advanced colorectal cancer patients. Data from 631 patients were collected from three different institutions. Globally, overall response rate was 35.8% (226 out of 631). Factors influencing response rate were 5FU dose intensity (high: 43.1%, low: 34.0%, P=0.03); oxaliplatin (yes: 45.8%, no: 22.9%, P-1: 40.4%, -1: 29.2%, P=0.004). In subgroup analysis significant differences in response rate between anaemic and nonanaemic patients were recorded in those patients treated with infusional chemotherapies (45.7 vs 25.5%, P

Original languageEnglish
Pages (from-to)13-20
Number of pages8
JournalBritish Journal of Cancer
Volume95
Issue number1
DOIs
Publication statusPublished - Jul 3 2006

Fingerprint

Colorectal Neoplasms
Hemoglobins
Drug Therapy
oxaliplatin
Fluorouracil

Keywords

  • 5-fluorouracil
  • Activity
  • Anaemia
  • Colorectal neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tampellini, M., Saini, A., Alabiso, I., Bitossi, R., Brizzi, M. P., Sculli, C. M., ... Dogliotti, L. (2006). The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients. British Journal of Cancer, 95(1), 13-20. https://doi.org/10.1038/sj.bjc.6603204

The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients. / Tampellini, M.; Saini, A.; Alabiso, I.; Bitossi, R.; Brizzi, M. P.; Sculli, C. M.; Berruti, A.; Gorzegno, G.; Magnino, A.; Sperti, E.; Miraglia, S.; Forti, L.; Alabiso, O.; Aglietta, M.; Harris, A.; Dogliotti, L.

In: British Journal of Cancer, Vol. 95, No. 1, 03.07.2006, p. 13-20.

Research output: Contribution to journalArticle

Tampellini, M, Saini, A, Alabiso, I, Bitossi, R, Brizzi, MP, Sculli, CM, Berruti, A, Gorzegno, G, Magnino, A, Sperti, E, Miraglia, S, Forti, L, Alabiso, O, Aglietta, M, Harris, A & Dogliotti, L 2006, 'The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients', British Journal of Cancer, vol. 95, no. 1, pp. 13-20. https://doi.org/10.1038/sj.bjc.6603204
Tampellini, M. ; Saini, A. ; Alabiso, I. ; Bitossi, R. ; Brizzi, M. P. ; Sculli, C. M. ; Berruti, A. ; Gorzegno, G. ; Magnino, A. ; Sperti, E. ; Miraglia, S. ; Forti, L. ; Alabiso, O. ; Aglietta, M. ; Harris, A. ; Dogliotti, L. / The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients. In: British Journal of Cancer. 2006 ; Vol. 95, No. 1. pp. 13-20.
@article{1bc279f6f68e4f788f4c63d3aeb69e75,
title = "The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients",
abstract = "The purpose of the study was to evaluate the influence of baseline haemoglobin level in predicting response to 5-fluorouracil (5FU)-based first-line chemotherapy in advanced colorectal cancer patients. Data from 631 patients were collected from three different institutions. Globally, overall response rate was 35.8{\%} (226 out of 631). Factors influencing response rate were 5FU dose intensity (high: 43.1{\%}, low: 34.0{\%}, P=0.03); oxaliplatin (yes: 45.8{\%}, no: 22.9{\%}, P-1: 40.4{\%}, -1: 29.2{\%}, P=0.004). In subgroup analysis significant differences in response rate between anaemic and nonanaemic patients were recorded in those patients treated with infusional chemotherapies (45.7 vs 25.5{\%}, P",
keywords = "5-fluorouracil, Activity, Anaemia, Colorectal neoplasms",
author = "M. Tampellini and A. Saini and I. Alabiso and R. Bitossi and Brizzi, {M. P.} and Sculli, {C. M.} and A. Berruti and G. Gorzegno and A. Magnino and E. Sperti and S. Miraglia and L. Forti and O. Alabiso and M. Aglietta and A. Harris and L. Dogliotti",
year = "2006",
month = "7",
day = "3",
doi = "10.1038/sj.bjc.6603204",
language = "English",
volume = "95",
pages = "13--20",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients

AU - Tampellini, M.

AU - Saini, A.

AU - Alabiso, I.

AU - Bitossi, R.

AU - Brizzi, M. P.

AU - Sculli, C. M.

AU - Berruti, A.

AU - Gorzegno, G.

AU - Magnino, A.

AU - Sperti, E.

AU - Miraglia, S.

AU - Forti, L.

AU - Alabiso, O.

AU - Aglietta, M.

AU - Harris, A.

AU - Dogliotti, L.

PY - 2006/7/3

Y1 - 2006/7/3

N2 - The purpose of the study was to evaluate the influence of baseline haemoglobin level in predicting response to 5-fluorouracil (5FU)-based first-line chemotherapy in advanced colorectal cancer patients. Data from 631 patients were collected from three different institutions. Globally, overall response rate was 35.8% (226 out of 631). Factors influencing response rate were 5FU dose intensity (high: 43.1%, low: 34.0%, P=0.03); oxaliplatin (yes: 45.8%, no: 22.9%, P-1: 40.4%, -1: 29.2%, P=0.004). In subgroup analysis significant differences in response rate between anaemic and nonanaemic patients were recorded in those patients treated with infusional chemotherapies (45.7 vs 25.5%, P

AB - The purpose of the study was to evaluate the influence of baseline haemoglobin level in predicting response to 5-fluorouracil (5FU)-based first-line chemotherapy in advanced colorectal cancer patients. Data from 631 patients were collected from three different institutions. Globally, overall response rate was 35.8% (226 out of 631). Factors influencing response rate were 5FU dose intensity (high: 43.1%, low: 34.0%, P=0.03); oxaliplatin (yes: 45.8%, no: 22.9%, P-1: 40.4%, -1: 29.2%, P=0.004). In subgroup analysis significant differences in response rate between anaemic and nonanaemic patients were recorded in those patients treated with infusional chemotherapies (45.7 vs 25.5%, P

KW - 5-fluorouracil

KW - Activity

KW - Anaemia

KW - Colorectal neoplasms

UR - http://www.scopus.com/inward/record.url?scp=33745563837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745563837&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6603204

DO - 10.1038/sj.bjc.6603204

M3 - Article

C2 - 16773070

AN - SCOPUS:33745563837

VL - 95

SP - 13

EP - 20

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 1

ER -